Verena Hultsch
![Verena Hultsch Verena Hultsch](https://dermatology-drugdevelopment.com/wp-content/uploads/sites/140/2024/06/Verena-Hultsch-150x150.png)
Company: Sanofi
Job title: Global Lead for BP, Dupilumab, Dermatology
Seminars:
Bullous Pemphigoid: Exploring New Frontiers 3:30 pm
Describe the heterogenous clinical presentations, disease burden, and diagnosis of bullous pemphigoid (BP) Highlight current understanding of BP pathophysiology and the critical role of autoimmunity and type 2 inflammation in both clinical signs and itch Discuss unmet needs from a clinical management perspective and how targeted therapies may address themRead more
day: Conference Day Two
Patient Recruitment in Rare Disease & Competitive Drug Development Landscapes: Enhancing Efficiency & Shortening Timelines to Clinical Development 3:30 pm
The dermatological drug development field is expanding fast, with a growing pipeline of therapies targeting disease, both high in prevalence, in addition to pathogenesis insights driving progress for rarer disease populations. With therapeutic breakthroughs for patients on the horizon, this workshop provides a crucial platform to address bottlenecks around recruitment, in order to meet needed…Read more
day: Pre-Conference Workshops